Pfizer, BioNTech Submit EUA Request for Bivalent COVID-19 Vaccine in Younger Children
The bivalent vaccine contains the original strain of the SARS-CoV-2 virus and a strain from the BA.4 and BA.5 lineages of the Omicron variant.
Diagnosis & Disease Information
Nearly Half of Adults Not Planning or Hesitant to Get Flu Vaccine
NFID survey show beliefs about influenza and pneumococcal disease, as well as attitudes and practices around vaccination, including the impacts of the COVID-19 pandemic.
Hypertension Affects Efficacy of COVID-19 Vaccine With Inactivated Virus
What factors influence the effectiveness of COVID-19 vaccination with inactivated virus? Two studies of Indonesian health care workers explored this question.
The Case for Expanding Pharmacists’ Authority to Administer Vaccines
Dr Robert Popovian discusses access to immunization services among adults in low-income communities and efforts to expand pharmacists’ authority to administer vaccines to increase vaccination rates for this vulnerable population.
Adjuvanted Enterovirus 71 Vaccine Is Highly Effective in Infants and Children
Researchers assessed the efficacy of an adjuvanted enterovirus 71 (EV71) vaccine for the prevention of EV71-associated infections among infants and children.
Alternative Tick-Borne Encephalitis Vaccination Schedule May Be Needed in Children
Researchers conducted a retrospective review that evaluated the field effectiveness of tick-borne encephalitis vaccination across all patient age groups.
Does Heterologous COVID-19 Vaccination Protect Against Seasonal Coronaviruses?
Researchers conducted a study to determine whether homologous COVID-19 vaccination increases in vitro neutralizing activity against seasonal human coronaviruses.
Comparison of COVID-19 Variants of Concern: Is Omicron Less Severe?
Researchers sought to assess outcomes among patients in South Africa who were hospitalized with COVID-19 infection during the Omicron wave compared with previous waves.
Influenza Vaccination Cuts Risk of Critical Illness in Children
During a season predominated by 2 vaccine-mismatched viruses, vaccination was estimated to reduce the risk of life-threatening influenza illness by 75%.
Efficacy, Safety of the Ad5-nCoV Vaccine for Protection Against COVID-19
Researchers conducted a study to determine the safety and efficacy of the Ad5-nCoV vaccine for protection against SARS-CoV-2 infection in adult patients.
- Loading...
Loading...
Loading... 
Loading...